Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz
Mainz, RLP, 55131, Germany
NCT Number: NCT01391078
This prospective, crossover study is designed to correlate SENSIMED Triggerfish® (TF) continuous IOP monitoring with conventional 24 h intraocular pressure profiles in glaucoma patients. There are two control measurements: The GAT/Perkins profile in the same eye in the second night and the GAT/Perkins profile in the same night in the fellow eye. Therefore, each eye serves as test eye and also as control for the second test eye.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Mainz, RLP, 55131, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
IOP will be monitored for 24 hours
IOP will be measured every two hours within 24 hours
Time frame: 48 hours
Correlation of GAT/Perkins values with TF data (mean, min, max, fluctuation)
Time frame: 48 hours
Correlation of GAT/Perkins values with TF data (mean, min, max, fluctuation)
Time frame: 48 hours
Correlation of GAT/Perkins values in the right and left eye (mean, min, max, fluctuation)
Time frame: 48 hours
Correlation of TF data right and left eye (mean, min, max, fluctuation)
Time frame: 48 hours
Correlation of GAT/Perkins values and TF data with systolic and diastolic blood pressure(mean, min, max, fluctuation)
Time frame: 48 hours
Correlation of GAT/Perkins values and TF data with pulse rate(mean, min, max, fluctuation)
Katrin Lorenz
Other
Comparison of Sensimed Triggerfish (TF) 24 Hour IOP Monitoring With Goldmann Applanation Tonometry (GAT) and Perkins Tonometry in Glaucoma Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06144918
Eye Diseases, Glaucoma
Glendale, California, United States
View Trial DetailsNCT06745856
Eye Diseases, Glaucoma
View Trial DetailsNCT04742283
Eye Diseases, Glaucoma
Chandler, Arizona, United States
View Trial DetailsNCT04747808
Eye Diseases, Glaucoma
Newport Beach, California, United States
View Trial Details